-
ALSO READ
Patent waiver in WTO to enable timely availability of Covid vaccines: Govt
India asks WTO members to finish talks on vaccine patent waiver by July-end
India urges WTO members to reach consensus on TRIPS waiver proposal
US support for Covid patent waiver will push WTO talks, says WTO chief
Patent waiver not enough for vax rollout, expand production: WTO chief
-
Five member states of the World Trade Organisation (WTO) alone will account for three-quarters of the entire global output of COVID-19 vaccines this year, said Director-General Ngozi Okonjo-Iweala on Wednesday.
"Production remains highly centralised - about 75 per cent of this year's vaccines appear set to come from five WTO members - China, India, Germany, the United States, and France," the WTO Director-General said at a high-level dialogue on "Expanding COVID-19 vaccine manufacture to promote equitable access."
Okonjo-Iweala said discriminatory access to vaccines is a root cause of the unequal recovery of the global economy, in which developed economies are rebounding quickly while the rest are lagging behind.
The lack of full transparency in vaccine supply deals is another reason for concern, she said as the world administered worldwide 1.1 billion COVID vaccine doses in June.
"Of those 1.1 billion doses in June, only 1.4 per cent went to Africans, who account for 17 per cent of the global population. Only 0.24 per cent went to people in low-income countries. And both shares declined even further in the first half of July," she said.
"In developed countries, 94 doses have been administered for every 100 residents. In Africa, the figure is 4.5 per cent. In low-income countries, it's 1.6 per cent. In Africa, only 20 million people, or 1.5 per cent of the population, are fully vaccinated, compared to 42 per cent of people in developed countries. We cannot accept this, for moral, practical, and economic reasons.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor






RECOMMENDED FOR YOU